Interleukin-12 Antagonist [EPC]

100556 reported adverse events

Drugs of this class: USTEKINUMAB USTEKINUMAB-TTWE USTEKINUMAB-AAUZ USTEKINUMAB-AEKN USTEKINUMAB-AUUB USTEKINUMAB-HMNY USTEKINUMAB-STBA

These side effects are most commonly reported by patients taking drugs of the Interleukin-12 Antagonist [EPC] class:

#	Side effect	Count
0	DRUG INEFFECTIVE	14604
1	OFF LABEL USE	12524
2	PRODUCT DOSE OMISSION ISSUE	9937
3	FATIGUE	6719
4	PSORIASIS	6521
5	PAIN	6135
6	CROHN^S DISEASE	5742
7	ARTHRALGIA	5728
8	RASH	5544
9	PRODUCT USE ISSUE	5374

See all common reactions for Interleukin-12 Antagonist [EPC]

Drugs of the Interleukin-12 Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	SWOLLEN JOINT COUNT INCREASED	1843	0.6245
1	ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY	405	0.6193
2	RHEUMATIC FEVER	2439	0.5888
3	LUPUS VULGARIS	625	0.5803
4	C-REACTIVE PROTEIN	474	0.5473
5	DEEP VEIN THROMBOSIS POSTOPERATIVE	1009	0.5448
6	RHEUMATOID FACTOR POSITIVE	2882	0.5156
7	ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE	3504	0.5136
8	SWOLLEN JOINT COUNT	113	0.5000
9	GRIP STRENGTH	113	0.4978

See all enriched reactions for Interleukin-12 Antagonist [EPC]